Alternative splicing: a new drug target of the post-genome era.
暂无分享,去创建一个
[1] J. Bell,et al. STY, a tyrosine-phosphorylating enzyme with sequence homology to serine/threonine kinases , 1991, Molecular and cellular biology.
[2] M. Garcia-Blanco,et al. Both phosphorylation and dephosphorylation of ASF/SF2 are required for pre-mRNA splicing in vitro. , 1997, RNA.
[3] M. Yanagida,et al. Fission Yeast Mitotic Regulator Dsk1 Is an SR Protein-specific Kinase* , 1998, The Journal of Biological Chemistry.
[4] A. Krainer,et al. A specific subset of SR proteins shuttles continuously between the nucleus and the cytoplasm. , 1998, Genes & development.
[5] E. Androphy,et al. Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients. , 2001, Human molecular genetics.
[6] Lin Jin,et al. Aberrant RNA Processing in a Neurodegenerative Disease: the Cause for Absent EAAT2, a Glutamate Transporter, in Amyotrophic Lateral Sclerosis , 1998, Neuron.
[7] G. Akusjärvi,et al. Functional inactivation of the SR family of splicing factors during a vaccinia virus infection , 2002, EMBO reports.
[8] C. Bailly,et al. Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506. , 2001, Cancer research.
[9] T. Pawson,et al. A mammalian protein kinase with potential for serine/threonine and tyrosine phosphorylation is related to cell cycle regulators. , 1991, The EMBO journal.
[10] P. Herrlich,et al. Participation in normal immune responses of a metastasis-inducing splice variant of CD44. , 1992, Science.
[11] J. Egebjerg,et al. ASF/SF2 and SC35 regulate the glutamate receptor subunit 2 alternative flip/flop splicing , 2005, FEBS letters.
[12] S. Riva,et al. Phosphorylation of human hnRNP protein A1 abrogates in vitro strand annealing activity. , 1993, Nucleic acids research.
[13] William Arbuthnot Sir Lane,et al. A serine kinase regulates intracellular localization of splicing factors in the cell cycle , 1994, Nature.
[14] R. Kole,et al. Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing. , 2003, The Journal of clinical investigation.
[15] P. Herrlich,et al. Regulation of alternative pre‐mRNA splicing by the ERK MAP‐kinase pathway , 2001, The EMBO journal.
[16] Stefan Stamm,et al. Signals and their transduction pathways regulating alternative splicing: a new dimension of the human genome. , 2002, Human molecular genetics.
[17] M B Roth,et al. SR proteins: a conserved family of pre-mRNA splicing factors. , 1992, Genes & development.
[18] J. Valcárcel,et al. Alternative pre-mRNA splicing: the logic of combinatorial control. , 2000, Trends in biochemical sciences.
[19] B. Dallapiccola,et al. Survival motor neuron gene transcript analysis in muscles from spinal muscular atrophy patients. , 1995, Biochemical and biophysical research communications.
[20] A. Krainer,et al. Functional analysis of pre‐mRNA splicing factor SF2/ASF structural domains. , 1993, The EMBO journal.
[21] T. Tsukahara,et al. Cloning and characterization of two neural‐salient serine/arginine‐rich (NSSR) proteins involved in the regulation of alternative splicing in neurones , 1999, Genes to cells : devoted to molecular & cellular mechanisms.
[22] R. Sandri-Goldin,et al. ICP27 interacts with SRPK1 to mediate HSV splicing inhibition by altering SR protein phosphorylation , 2003, The EMBO journal.
[23] J. Manley,et al. Phosphorylation of the ASF/SF2 RS domain affects both protein-protein and protein-RNA interactions and is necessary for splicing. , 1997, Genes & development.
[24] J. Weissenbach,et al. Identification and characterization of a spinal muscular atrophy-determining gene , 1995, Cell.
[25] D. Black. Mechanisms of alternative pre-messenger RNA splicing. , 2003, Annual review of biochemistry.
[26] T. Maniatis,et al. Common themes in the function of transcription and splicing enhancers. , 1997, Current opinion in cell biology.
[27] P. Herrlich,et al. Heterogeneous Ribonucleoprotein A1 Is Part of an Exon-specific Splice-silencing Complex Controlled by Oncogenic Signaling Pathways* , 2000, The Journal of Biological Chemistry.
[28] J. Wyatt,et al. Insulin Regulates Alternative Splicing of Protein Kinase C βII through a Phosphatidylinositol 3-Kinase-dependent Pathway Involving the Nuclear Serine/Arginine-rich Splicing Factor, SRp40, in Skeletal Muscle Cells* , 2001, The Journal of Biological Chemistry.
[29] G. Kéri,et al. Synthesis of selective SRPK-1 inhibitors: novel tricyclic quinoxaline derivatives. , 2005, Bioorganic & medicinal chemistry letters.
[30] Kristen W. Lynch,et al. Consequences of regulated pre-mRNA splicing in the immune system , 2004, Nature Reviews Immunology.
[31] Y. Lazebnik,et al. Identification of an endogenous dominant-negative short isoform of caspase-9 that can regulate apoptosis. , 1999, Cancer research.
[32] P. Herrlich,et al. CD44: From adhesion molecules to signalling regulators , 2003, Nature Reviews Molecular Cell Biology.
[33] M. Diaz-Meco,et al. Identification of Heterogeneous Ribonucleoprotein A1 as a Novel Substrate for Protein Kinase C ζ (*) , 1995, The Journal of Biological Chemistry.
[34] A. Zahler,et al. Two members of a conserved family of nuclear phosphoproteins are involved in pre-mRNA splicing. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[35] S. Fox,et al. Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms. , 1994, Cancer research.
[36] B. Graveley,et al. Exon-specific RNA interference: a tool to determine the functional relevance of proteins encoded by alternatively spliced mRNAs. , 2005, Methods in molecular biology.
[37] K. Eguchi,et al. Regulation of alternative splicing of caspase-2 through an intracellular signaling pathway in response to pro-apoptotic stimuli. , 2005, The Journal of laboratory and clinical medicine.
[38] Jiuyong Xie,et al. Control of alternative splicing of potassium channels by stress hormones. , 1998, Science.
[39] A. Krainer,et al. Regulation of heterogenous nuclear ribonucleoprotein A1 transport by phosphorylation in cells stressed by osmotic shock. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[40] A. Krainer,et al. Serine Phosphorylation of SR Proteins Is Required for Their Recruitment to Sites of Transcription In Vivo , 1998, The Journal of cell biology.
[41] Y. Hannun,et al. De Novo Ceramide Regulates the Alternative Splicing of Caspase 9 and Bcl-x in A549 Lung Adenocarcinoma Cells , 2002, The Journal of Biological Chemistry.
[42] A. Das,et al. Diospyrin, a bisnaphthoquinone: a novel inhibitor of type I DNA topoisomerase of Leishmania donovani. , 1998, Molecular pharmacology.
[43] P. Herrlich,et al. Signal-dependent regulation of splicing via phosphorylation of Sam68 , 2002, Nature.
[44] D. Black,et al. A CaMK IV responsive RNA element mediates depolarization-induced alternative splicing of ion channels , 2001, Nature.
[45] T. Cooper,et al. Pre-mRNA splicing and human disease. , 2003, Genes & development.
[46] M. Hagiwara,et al. SPK-1, a C. elegans SR protein kinase homologue, is essential for embryogenesis and required for germline development , 2000, Mechanisms of Development.
[47] J. Tazi,et al. Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I , 1996, Nature.
[48] M. Hagiwara,et al. Novel SR-protein-specific kinase, SRPK2, disassembles nuclear speckles. , 1998, Biochemical and biophysical research communications.
[49] M. Hagiwara,et al. Cloning of Human PRP4 Reveals Interaction with Clk1* , 2001, The Journal of Biological Chemistry.
[50] A. Krainer,et al. Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. , 1994, Science.
[51] D. Price,et al. Purification of P-TEFb, a Transcription Factor Required for the Transition into Productive Elongation (*) , 1995, The Journal of Biological Chemistry.
[52] Y. Rao,et al. Regulation of Ich-1 pre-mRNA alternative splicing and apoptosis by mammalian splicing factors. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[53] C. Bailly,et al. Selective Inhibition of Topoisomerase I and Various Steps of Spliceosome Assembly by Diospyrin Derivatives , 2005, Molecular Pharmacology.
[54] J. Castle,et al. Genome-Wide Survey of Human Alternative Pre-mRNA Splicing with Exon Junction Microarrays , 2003, Science.
[55] Y. Jong,et al. Treatment of spinal muscular atrophy by sodium butyrate , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[56] Robert V Farese,et al. Regulation of Alternative Splicing of Protein Kinase Cβ by Insulin (*) , 1995, The Journal of Biological Chemistry.
[57] D. Cooper,et al. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: Causes and consequences , 1992, Human Genetics.
[58] S. Nishimura,et al. Novel antitumor indolocarbazole compound 6-N-formylamino-12,13-dihydro-1,11- dihydroxy-13-(beta-D-glucopyranosyl)-5H-indolo[2,3-a]pyrrolo[3,4- c]carbazole-5,7(6H)-dione (NB-506): induction of topoisomerase I-mediated DNA cleavage and mechanisms of cell line-selective cytotoxicity. , 1995, Cancer research.
[59] Adrian R. Krainer,et al. Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2 , 1992, Cell.
[60] J. Bell,et al. In vivo regulation of alternative pre-mRNA splicing by the Clk1 protein kinase , 1997, Molecular and cellular biology.
[61] A. Ullrich,et al. Identification of SRPK1 and SRPK2 as the Major Cellular Protein Kinases Phosphorylating Hepatitis B Virus Core Protein , 2002, Journal of Virology.
[62] L. Cantley,et al. SRPK2: A Differentially Expressed SR Protein-specific Kinase Involved in Mediating the Interaction and Localization of Pre-mRNA Splicing Factors in Mammalian Cells , 1998, The Journal of cell biology.
[63] A. Krainer,et al. Correction of disease-associated exon skipping by synthetic exon-specific activators , 2003, Nature Structural Biology.
[64] T Pawson,et al. The Clk/Sty protein kinase phosphorylates SR splicing factors and regulates their intranuclear distribution. , 1996, The EMBO journal.
[65] C. Guthrie,et al. Conservation in budding yeast of a kinase specific for SR splicing factors. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[66] A. Kornblihtt,et al. Trypanosoma cruzi TcSRPK, the first protozoan member of the SRPK family, is biochemically and functionally conserved with metazoan SR protein-specific kinases. , 2003, Molecular and biochemical parasitology.
[67] J. Gui,et al. Purification and characterization of a kinase specific for the serine- and arginine-rich pre-mRNA splicing factors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[68] L. Corcos,et al. Topoisomerase I and II inhibitors control caspase-2 pre-messenger RNA splicing in human cells. , 2004, Molecular cancer research : MCR.
[69] C. Thompson,et al. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death , 1993, Cell.
[70] B. Sakmann,et al. Flip and flop: a cell-specific functional switch in glutamate-operated channels of the CNS. , 1990, Science.
[71] M. Hagiwara,et al. cdc2 kinase-mediated phosphorylation of splicing factor SF2/ASF. , 1998, Biochemical and biophysical research communications.
[72] P. Herrlich,et al. Coupling of signal transduction to alternative pre‐mRNA splicing by a composite splice regulator , 1998, The EMBO journal.
[73] P. Leder,et al. FBP WW domains and the Abl SH3 domain bind to a specific class of proline‐rich ligands , 1997, The EMBO journal.
[74] Hiroshi Kimura,et al. Manipulation of Alternative Splicing by a Newly Developed Inhibitor of Clks* , 2004, Journal of Biological Chemistry.
[75] S. Stamm,et al. The Cellular Localization of the Murine Serine/Arginine-rich Protein Kinase CLK2 Is Regulated by Serine 141 Autophosphorylation* , 1998, The Journal of Biological Chemistry.
[76] R. Weinmann,et al. Casein kinase type II is involved in the inhibition by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole of specific RNA polymerase II transcription. , 1986, The Journal of biological chemistry.
[77] S. Stamm,et al. Characterization and comparison of four serine- and arginine-rich (SR) protein kinases. , 1997, The Biochemical journal.
[78] C. Lorson,et al. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[79] A. Krainer,et al. The Mkk3/6-p38–Signaling Cascade Alters the Subcellular Distribution of Hnrnp A1 and Modulates Alternative Splicing Regulation , 2000, The Journal of cell biology.
[80] Christopher J. Lee,et al. Alternative splicing in the human, mouse and rat genomes is associated with an increased frequency of exon creation and/or loss , 2003, Nature Genetics.
[81] S. Stamm,et al. Ischemia Induces a Translocation of the Splicing Factor tra2-β1 and Changes Alternative Splicing Patterns in the Brain , 2002, The Journal of Neuroscience.
[82] J. McPherson,et al. A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. , 1999, Human molecular genetics.